NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes | Biotech Hunter

Enrollment

29,304

Participants

Timeline

Start Date

September 5, 2012

Primary Completion Date

December 30, 2013

Study Completion Date

December 30, 2013

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Interventions

OTHER

No treatment given

Patients will be asked to complete a two-part patient self-assessment questionnaire (SAQ) comprising a retrospective cross-sectional evaluation (Part 1), and a prospective observational evaluation (Part 2).

Trial Locations (24)

1025

Novo Nordisk Investigational Site, Budapest

1407

Novo Nordisk Investigational Site, Sofia

2300

Novo Nordisk Investigational Site, Copenhagen S

3542

Novo Nordisk Investigational Site, Riyadh

11070

Novo Nordisk Investigational Site, Belgrade

11844

Novo Nordisk Investigational Site, Amman

16000

Novo Nordisk Investigational Site, Prague

44425

Novo Nordisk Investigational Site, Kfar Saba

55127

Novo Nordisk Investigational Site, Mainz

119330

Novo Nordisk Investigational Site, Moscow

560001

Novo Nordisk Investigational Site, Bangalore

B1636DSU

Novo Nordisk Investigational Site, Prov. de Buenos Aires

A-1010

Novo Nordisk Investigational Site, Vienna

L4W 4XI

Novo Nordisk Investigational Site, Mississauga

10 000

Novo Nordisk Investigational Site, Zagreb

FI-02600

Novo Nordisk Investigational Site, Espoo

Unknown

Novo Nordisk Investigational Site, Selangor Darul Ehsan

Novo Nordisk Investigational Site, Mexico City

Novo Nordisk Investigational Site, Alphen aan den Rijn

PL-02-274

Novo Nordisk Investigational Site, Warsaw

010031

Novo Nordisk Investigational Site, Bucharest

811 05

Novo Nordisk Investigational Site, Bratislava

SI-1000

Novo Nordisk Investigational Site, Ljubljana

202 15

Novo Nordisk Investigational Site, Malmo